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INTRODUCTION
Herpes simplex virus type 2 (HSV-2) is one of the most common
sexually transmitted infection worldwide and the main cause of
genital ulcers. Although HSV-2 prevalence varies among
countries and population, it is more prevalent in developing
countries rather than developed countries. The World Health
Organization’s census showed that 60% of women, globally, are
HSV-2 infected. HSV-2 can be transmitted sexually, when ulcers
or lesions are present, or when skin is broken. HSV-2 is a
lifelong asymptomatic infection, however, antivirals can be used
to suppress the virus shedding. People with HSV-2 are at
increased risk for HIV acquisition and transmission, thus the
increase risk of perinatal transmission. Infants exposed to HSV-2
during vaginal delivery are associated with low birth weight,
premature birth, fetal malformations, or neurological disabilities.
OBJECTIVE
MATERIALS AND METHODS
Blood samples were collected from pregnant women from
Mysore subdistrict, India, in a previously completed project that
Public Health Research Institute of India (PHRII) conducted in
2011-2014 called Saving Children Improving Lives (SCIL). All
women were administered informed consent prior to the blood
draw. Pregnancy outcomes were documented immediately after
birth, and 3 and 6 months after delivery. From the SCIL study,
306 random serum samples were analyzed based on their
adverse birth outcomes. HerpeSelect 2 ELISA IgG kit (Focus
Diagnostics, USA) was used to test the serum samples for HSV-
2 specific antibodies. Samples that were equivocal or close to
equivocal, above 0.75 Index Value (IV), were retested in in a
separate ELISA plate. An HSV-2 IgG/IgM Rapid Test kit was
also used to retest the ELISA positive serum samples, as well as
the samples that differed between the two ELISA tests.
RESULTS
CONCLUSIONS
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Of the 306 women 
tested during 
childbirth from rural 
areas of Mysore, 
India, 5.6% were 
positive for genital 
herpes
The objective of this project is to evaluate the prevalence of
HSV-2 among pregnant women during childbirth and the
correlation HSV-2 has with adverse birth outcomes.
Out of the 306 serum samples tested, 17 (5.6%) samples
were positive, nine (2.94%) were high positive, eight (2.61%)
were low positive, two were equivocal and the remaining
serum samples were negative. The HSV-2 IgG/IgM Rapid
test detected nine samples positive for HSV-2 IgG
antibodies; eight from the high positive and one from the low
positive serum samples. Data will be analyzed for correlation
between positive serum samples and the birth outcomes.
Informing the HSV-2 positive women and offering treatment
will reduce HSV-2 transmission rate and birth defects.
Figure 1. HSV-2 ELISA.
Figure 1 shows the last ELISA plate that 
was performed during this project. The 
yellow wells are the positive results. 
Each sample is placed into two wells. 
This plate was then inserted into the 
spectrophotometer to determine the 
absorbance level.
Figure 2. HSV-2 IgG/IgM Rapid 
Test.
This test was used to reinforce the 
results from the ELISA. The line 
next to C confirms that the test is 
valid. Since there is a line next to 
G, this sample is positive for HSV-2 
IgG antibody. Since a line is absent 
next to M, there were no IgM 
antibodies detected. Table 1. Ranges that determine the 
results from the ELISA
These ranges were used for the Index 
Values (IV) which determine whether 
each well is positive, equivocal or 
negative. The IV is calculated from the 
absorbance reading and the average of 
the Cut-Off Calibrators.
Table 2. Results from all the ELISA
These are the results from all 8 ELISAs using the ranges from Table 1. Some 
samples were tested twice using the ELISA. Samples that were positive, equivocal 
or differed between the two ELISA tests were tested with the Rapid Test, shown in 
Figure 2. 
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